Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Rocket Lab Stock (RKLB) Opinions on Iridium Acquisition and Analyst Reports

None

Analyst Upgrade Spotlight: Market observers noted Morgan Stanley's decision to maintain an Overweight rating on Rocket Lab while elevating its bull case price target to $293. Discussion emphasized the firm's view that the Iridium acquisition enhances the company's position as a vertically integrated space platform. This development drew attention to potential long-term revenue synergies in connectivity services.

Acquisition Strategy Focus: Social media commentary highlighted how recent acquisitions, including Iridium, are structured to operate as independent units under Rocket Lab's umbrella. Participants pointed to sustained growth in the contract backlog and improved liquidity from capital raises as key factors supporting operational scaling. These elements were framed as strengthening the balance sheet amid ongoing investments.

Neutron Development Updates: Attention turned to steady progress on the Neutron rocket program as a potential catalyst for the second half of 2026. Observers referenced busy launch schedules for the Electron vehicle and expectations for revenue growth alongside margin expansion. Overall conversation reflected a positive tone around the company's trajectory in the space sector.

Note: This discussion summary was generated from an AI condensation of post data.

Rocket Lab Insider Trading Activity

RKLB Insider Trades

Rocket Lab insiders have traded $RKLB stock on the open market 106 times in the past 6 months. Of those trades, 0 have been purchases and 106 have been sales.

Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

  • PETER BECK (CEO) has made 0 purchases and 29 sales selling 3,294,636 shares for an estimated $287,722,452.
  • ARJUN KAMPANI (SVP & General Counsel) has made 0 purchases and 27 sales selling 262,944 shares for an estimated $30,965,212.
  • ALEXANDER R SLUSKY has made 0 purchases and 7 sales selling 200,000 shares for an estimated $25,715,726.
  • FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 24 sales selling 162,500 shares for an estimated $17,503,775.
  • ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 11 sales selling 125,488 shares for an estimated $13,311,980.
  • MARVIN BRADFORD CLEVENGER (President, Rocket Lab USA, Inc) has made 0 purchases and 7 sales selling 19,049 shares for an estimated $2,730,231.
  • MERLINE SAINTIL sold 18,126 shares for an estimated $1,360,171

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

Rocket Lab Revenue

RKLB Quarterly Revenue

Rocket Lab had revenues of $200.3M in Q1 2026. This is an increase of 63.46% from the same period in the prior year.

You can track RKLB financials on Quiver Quantitative's RKLB stock page.

You can access data on RKLB stock through the Quiver Quantitative API.

Rocket Lab Hedge Fund Activity

We have seen 555 institutional investors add shares of Rocket Lab stock to their portfolio, and 309 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Rocket Lab Government Contracts

We have seen $25,408,081 of award payments to $RKLB over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

Rocket Lab Price Targets

Multiple analysts have issued price targets for $RKLB recently. We have seen 13 analysts offer price targets for $RKLB in the last 6 months, with a median target of $120.0.

Here are some recent targets:

  • Ryan Koontz from Needham set a target price of $120.0 on 06/30/2026
  • Suji Desilva from Roth Capital set a target price of $130.0 on 06/30/2026
  • Jeff Van Rhee from Craig-Hallum set a target price of $120.0 on 06/30/2026
  • Ronald Epstein from B of A Securities set a target price of $115.0 on 06/30/2026
  • Andres Sheppard from Cantor Fitzgerald set a target price of $96.0 on 06/30/2026
  • Trevor Walsh from Citizens set a target price of $130.0 on 06/30/2026
  • Michael Leshock from Keybanc set a target price of $135.0 on 06/15/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles